CMS

New court filings and lobbying reports reveal an industry drive to tamp down critics — and retain billions of dollars in overcharges. What is the Centers for Medicare & Medicaid Services doing about it?

Federal regulators provided more specifics about why they suspended two private sector sites, including concerns about potential overseas accessing of consumer data and suspicions of involvement in enrollment and switching schemes.

A private 2014 decision by the Centers for Medicare & Medicaid Services faces new scrutiny in a multibillion-dollar Justice Department fraud case against UnitedHealth Group.

The GUIDE Model is designed to facilitate comprehensive, coordinated care that improves the quality of life for people with dementia and reduces the strain on their unpaid caregivers.

CMS says it has received more than 200,000 complaints in the first six months of the year about people being signed up for Obamacare plans or switched to new plans without their consent.

The judge dismissed the state's lawsuit against two federal agencies and said the case should instead be an administrative challenge. Next stop is the 11th U.S. Circuit Court of Appeals in Atlanta.

The new rule threatens the loss of insurance funds in an attempt to prevent discrimination based on sex, including gender identity. The judge wrote that state agencies faced "imminent injury" because of the rule.

A flood of litigation — with plaintiffs like small businesses, drugmakers, and hospitals challenging regulations — could leave the country with a patchwork of disparate health regulations.

The program, which began in March after the ramsomware attack on Change Healthcare, will close July 12. Providers are now successfully billing Medicare, the agency said.

President Joe Biden is campaigning on his efforts to cut drug costs for Medicare patients. But independent pharmacists say one strategy makes it unaffordable for them to keep some brand-name medicines in stock.